# Quantitative GLP-1 Receptor Imaging Correlated to ex Vivo Distribution of In-111-exendin

> **NCT03889496** · NA · TERMINATED · sponsor: **Radboud University Medical Center** · enrollment: 12 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **RADIATION:** indium-111-exendin SPECT/CT

## Key facts

- **NCT ID:** NCT03889496
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-11-16
- **Primary completion:** 2021-06-14
- **Final completion:** 2021-06-14
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Because of the COVID-19 pandemic, funding for the trial was terminated and attempts to find alternative sources of funding were to no avail.
- **Last updated:** 2023-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03889496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03889496, "Quantitative GLP-1 Receptor Imaging Correlated to ex Vivo Distribution of In-111-exendin". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT03889496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*